StockNews.com Upgrades Regeneron Pharmaceuticals (NASDAQ:REGN) to Strong-Buy
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) was upgraded by research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Wednesday. A number of other equities analysts also recently commented on REGN. Royal Bank of Canada lifted their price target on Regeneron Pharmaceuticals from $1,252.00 to […]
11 Oct 02:17 · The Cerbat Gem